What Is the Price-to-Sales Ratio (P/S)? When to Use It
Quick answer: The price-to-sales ratio (P/S) divides a company's market capitalization by its annual revenue. A P/S of 5 means investors are paying $5 for every $1 of annual revenue. It's most useful for early-stage companies that aren't yet profitable — where P/E ratios don't apply — and for comparing companies within the same sector. Its biggest limitation: it ignores profitability entirely, which makes it easy to overpay for revenue growth that never converts to earnings.
How P/S is calculated
Price-to-Sales = Market Capitalization ÷ Annual Revenue
Or per share: Stock Price ÷ Revenue Per Share
Example: a company with a $5 billion market cap and $1 billion in annual revenue has a P/S ratio of 5x.
When P/S is most useful
Pre-profit growth companies. When a company has no earnings to value, P/E doesn't work. P/S gives a valuation anchor based on revenue — the nearest thing to a measurable output for companies still investing heavily for growth.
Cyclical businesses at the bottom of the cycle. When earnings are temporarily depressed or negative due to cyclical conditions, P/E ratios look extremely high or meaningless. P/S may better represent normalized business value through the cycle.
Comparing within sectors. Businesses in the same sector with similar business models and margin profiles can be reasonably compared on P/S — a software company at 8x P/S vs a peer at 4x P/S raises the question of why the premium exists.
The critical limitation: profitability is everything
Revenue with no path to profit is worth very little. A company generating $500 million in revenue while losing $200 million per year is not worth 10x revenue — it's worth whatever the discounted future cash flows are, which depends entirely on when and how much profit it will eventually generate.
The danger of P/S during growth market bubbles: investors pay 20–30x revenue for fast-growing companies, assuming that the high gross margins will eventually translate to high net margins. When growth slows before profitability arrives, these valuations collapse dramatically.
Always pair P/S with gross margin data. A software company with 75% gross margins at 15x P/S is in a completely different position than a marketplace business with 40% gross margins at the same multiple — the path to net profitability is much clearer for the high-margin business.
Professor Aswath Damodaran of NYU Stern Business School uses price-to-sales as one input among many in sector analysis, but emphasizes that it's only meaningful in the context of margin expectations. Paying a high P/S for revenue that will never generate adequate margins is simply overpaying — the multiple is a shortcut that can badly mislead when not paired with profitability analysis. — The Little Book of Valuation, Wiley
What different P/S levels suggest by sector
P/S varies enormously by sector — comparison must be within the same industry:
- High-growth SaaS software: 8–20x P/S (high gross margins justify premium)
- Established software: 4–10x P/S
- Biotech (pre-revenue): valued on pipeline, not P/S
- Consumer brands: 2–5x P/S
- Retail: 0.3–1x P/S (thin margins mean low revenue multiples)
- Manufacturing: 0.5–2x P/S
AlphaLens does this analysis in seconds
15 structured research frameworks. Any US stock. Live SEC filings, real-time news, powered by Advanced AI.
Try AlphaLens Free → Use code REDDIT-FREE-TRIAL · No card required · Then $39/mo or $299/yrHow AlphaLens uses P/S
The Fair Value Stress Test incorporates P/S as one of several valuation approaches — particularly for growth companies where DCF assumptions are highly uncertain. The Revenue Quality Decomposer verifies that the revenue being valued is recurring and sustainable. The Earnings Quality Analyzer tracks the trajectory from revenue to profitability, ensuring that the P/S multiple is being applied to a realistic path to earnings.
Where to go deeper
For a detailed walkthrough of each research framework, see the complete guide to all 15 AlphaLens frameworks.
For definitions of investing terms, see the AlphaLens investing glossary.